Related Experiment Video
Updated: Sep 26, 2026

Murine Prostate Micro-dissection and Surgical Castration
Published on: May 11, 2016
Beta-catenin-related anomalies in apoptosis-resistant and hormone-refractory prostate cancer cells
Alexandre de la Taille1, Mark A Rubin, Min-Wei Chen
1Department of Urology, Assistance Publique des Hôpitaux de Paris-CHU Mondor, 94000 Créteil, France. adelataille@hotmail.com
Purpose:
beta-Catenin is a critical end component of the wnt signaling pathway that regulates cell growth, apoptosis, and migratory behavior in response to intercellular adhesion molecules. The aim of this study was to evaluate abnormalities of beta-catenin protein expression, subcellular localization, and activity in an in vitro model of acquired apoptosis-resistance in cultured PC cells and in primary human prostate cancers (PrCa).
Experimental Design:
Apoptosis-resistant human prostate cancer cell line variants were derived from parental LNCaP cells by repeated brief exposure to apoptotic stimuli. The derivative and parental cells were analyzed for beta-catenin expression and intracellular localization using cell fractionation and Western blotting procedures. Endogenous transcriptional activity from the TCF/LEF-1 response element was also studied in these variants after transfection with a beta-catenin sensitive reporter plasmid. Finally, beta-catenin protein expression and intracellular localization were evaluated on 212 patients [122 localized PrCa and 90 hormone-refractory (HRPC) PrCa specimens by immunohistochemistry].
Results:
Western blot analysis showed that the intracellular partitioning of beta-catenin was shifted from the membrane fraction in parental cells to the cytoplasmic/nuclear fractions of the apoptosis-resistant cell lines. Coordinately, transcriptional activity from a TCF/LEF-promoted reporter plasmid was increased significantly in the apoptosis-resistant lines. In the primary prostate tumors analyzed, cytoplasmic and/or nuclear beta-catenin expression was correlated statistically with the HRPC status and Gleason score. In the group of localized PrCa, abnormal beta-catenin expression tended to be associated with a higher Gleason score and with pT3 disease. No mutation was found in patients with HRPC and abnormal beta-catenin expression.
Conclusion:
These data suggest that anomalies of beta-catenin expression occur in PrCa and that these anomalies are associated with disease progression, especially to the therapeutic-resistant state.
Insights
Abnormal beta-catenin expression and localization are linked to prostate cancer progression, particularly to a therapy-resistant state. These findings highlight beta-catenin
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Signaling
Background:
- Beta-catenin is a key protein in the Wnt signaling pathway, regulating cell growth and behavior.
- Dysregulation of beta-catenin is implicated in various cancers, including prostate cancer.
Purpose of the Study:
- To investigate beta-catenin expression, localization, and activity in prostate cancer.
- To evaluate these changes in an in vitro model of acquired apoptosis resistance and in primary prostate tumors.
Main Methods:
- Derived apoptosis-resistant prostate cancer cell lines from parental LNCaP cells.
- Analyzed beta-catenin expression and localization using Western blotting and cell fractionation.
- Assessed transcriptional activity using a beta-catenin-sensitive reporter plasmid.
- Evaluated beta-catenin in 212 primary prostate cancer specimens via immunohistochemistry.
Main Results:
- Apoptosis-resistant cells showed a shift of beta-catenin from membrane to cytoplasmic/nuclear fractions.
- Transcriptional activity of beta-catenin increased significantly in resistant cells.
- Nuclear/cytoplasmic beta-catenin correlated with hormone-refractory prostate cancer (HRPC) status and Gleason score.
- Abnormal beta-catenin in localized prostate cancer was associated with higher Gleason scores and advanced stage.
Conclusions:
- Anomalies in beta-catenin expression and localization occur in prostate cancer.
- These anomalies are associated with disease progression, especially the development of therapeutic resistance.
More Related Videos
Related Concept Videos
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Inhibition of Cdk Activity
Canonical Wnt Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation

